Respiratory Syncytial Virus Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Many chronic conditions, including pneumonia, bronchitis, asthma, and respiratory disease, are caused by the Respiratory Syncytial Virus (RSV). It primarily affects neonates, infants, and adults, resulting in outpatient visits, hospitalization, and, in some cases, death. As a result, early detection of RSV-related diseases is critical to avoid further medical complications.

Respiratory Syncytial Virus Diagnostics Market is a virus that causes respiratory infections like bronchiolitis and pneumonia. Globally, the number of RSV infections is increasing, fueling the demand for rapid diagnostic techniques. According to the CDC, each year in the United States, RSV hospitalizes approximately 1,32,000- 172,000 children under the age of five and kills approximately 14,000 adults over the age of 65.

The rising incidence of RSV infections is the primary driving force behind this market. Because the clinical symptoms of Respiratory Syncytial Virus Diagnostics Market infections are indistinguishable from those of other respiratory infections, there is an increasing need for rapid, specific, and sensitive diagnostic techniques. The current scarcity of specific treatment options, as well as the future development of Respiratory Syncytial Virus Diagnostics Market vaccines, are the major restraints for this market. Around 99% of RSV-related deaths in children under the age of five occur in developing countries, implying a greater demand for diagnostic methods in these countries.

By Technology, the RSV Diagnostic Market

Molecular Diagnostics, Immunoassays, Monoclonal Antibodies, Differential Light Scattering, Flow Cytometry, Artificial Intelligence, Chromatography, Diagnostic Imaging, Liposomes, Gel Microdroplets, and Others are the technologies that make up the RSV Diagnostic Market. Molecular Diagnostics has the highest sensitivity and specificity of these segments.

The RSV Diagnostic Market by End User:

Hospitals, nursing homes, commercial laboratories, and public health laboratories are major users of diagnostic kits.

Geographical Distribution of the RSV Diagnostic Market

The RSV diagnostic market includes North America, Europe, Asia Pacific, and the rest of the world. Because of the increasing cases of respiratory diseases, North America and Europe currently dominate the market.

Key Players

F. Hoffmann-La-Roche AG, Becton, Dickinson and Company, Novartis AG, Abbott Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioMerieux, DiaSorin SPA, Millipore-sigma, Quidel Corporation, Alere Inc., Coris BioConcept, Fast-track Diagnostics, and Quest Diagnostics are key players in the respiratory syncy